Semaglutide with B12 Injectable

Home Delivery option for self administration is available

Semaglutide belongs to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs. It mimics the GLP-1 hormone, released in the gut in response to eating. One role of GLP-1 is to prompt the body to produce more insulin which reduces blood sugar (glucose), interacts with the parts of the brain that suppress your appetite and signals you to feel full. When used in conjunction with diet and exercise, it can cause significant weight loss — and a reduced risk of cancer, heart disease and diabetes in people who are obese or overweight.
Reference

Semaglutide is administered once a week by injection and should be used under the guidance of a healthcare professional. The medication is sourced from a 503B Compounding Pharmacy who follows very specific standards and guidelines to ensure client safety.

There have been several anti-obesity medications that help suppress appetite and achieve weight loss. But semaglutide performs on a new level. An early study of obese clients showed half of the participants using semaglutide lost 15% of their body weight, and nearly a third lost 20%. Participants who incorporated only lifestyle changes lost about 2.4% of their weight.

The side effects of semaglutide are typically mild — especially when compared to the complications associated with overweight and obesity.

People taking semaglutide for weight loss may experience:

  • Dizziness

  • Fatigue

  • Gastrointestinal issues, such as diarrhea, constipation and gassiness

  • Headache

  • Stomach issues, including nausea, vomiting, pain or distension (bloat)

Gastrointestinal issues are the most common complaint among people just starting semaglutide. But you may be able to reduce the side effects by beginning on a lower dose and then slowly increasing the amount you take.

Ideal clients should:

Have a body mass index (BMI) of 27kg/m2 or greater and at least one weight-related condition, such as high blood pressure, Type 2 diabetes or high cholesterol, sleep apnea

Have a BMI of 30kg/m2 or greater

*Not for people who have a personal history of pancreatitis or allergy to GLP-1 medications, or a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2, or people with type 1 diabetes.

Joining fee is $650.

Includes- 7 week membership with 1 injection weekly, initial lab collection required prior to treatment, medical evaluation for appropriateness, MD and RN support. Medication ship to you.
Additional education/services also available at discounted rates with membership.

Continued weight loss membership fee determined
based on goals of client and dose needed.